Company Filing History:
Years Active: 2015
Title: The Innovative Contributions of Ming Ren
Introduction
Ming Ren is a notable inventor based in Tianjin, China. He has made significant contributions to the field of medicine, particularly in the area of traditional Chinese medicine. His work focuses on innovative solutions for health issues, showcasing the potential of integrating traditional practices with modern medical needs.
Latest Patents
Ming Ren holds a patent for the "Use of a Chinese medicine composition in preparing medicaments for treating secondary prevention of myocardial infarction." This invention relates to a unique formulation that combines various crude drugs in specific weight percentages. The composition includes Radix Astragali (22.2%–66.8%), Radix Salviae Miltiorrhizae (11.6%–33.4%), Radix Notoginseng (2.5%–13.5%), and Lignum Dalbergiae Odoriferae (14.5%–44.3%). This innovative approach aims to enhance the effectiveness of treatments for patients at risk of myocardial infarction.
Career Highlights
Ming Ren is associated with Tasly Pharmaceutical Group Co., Ltd., a prominent company in the pharmaceutical industry. His role at Tasly has allowed him to explore and develop new medicinal formulations that leverage the benefits of traditional Chinese medicine. His dedication to research and development has positioned him as a key figure in the advancement of medical treatments.
Collaborations
Ming Ren has collaborated with several professionals in his field, including Boli Zhang and Hongcai Shang. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, ultimately leading to the development of effective medicinal solutions.
Conclusion
Ming Ren's contributions to the field of medicine through his innovative patent highlight the importance of integrating traditional practices with modern medical approaches. His work not only addresses critical health issues but also paves the way for future advancements in the pharmaceutical industry.